Literature DB >> 12835315

Equilibrative nucleoside transporter family members from Leishmania donovani are electrogenic proton symporters.

Alex Stein1, Gayatri Vaseduvan, Nicola S Carter, Buddy Ullman, Scott M Landfear, Michael P Kavanaugh.   

Abstract

Leishmania donovani express two members of the equilibrative nucleoside transporter family; LdNT1 encoded by two closely related and linked genes, LdNT1.1 and LdNT1.2, that transport adenosine and pyrimidine nucleosides and LdNT2 that transports inosine and guanosine exclusively. LdNT1.1, LdNT1.2, and LdNT2 have been expressed in Xenopus laevis oocytes and found to be electrogenic in the presence of nucleoside ligands for which they mediate transport. Further analysis revealed that ligand uptake and transport currents through LdNT1-type transporters are proton-dependent. In addition to the flux of protons that is coupled to the transport reaction, LdNT1 transporters mediate a variable constitutive proton conductance that is blocked by substrates and dipyridamole. Surprisingly, LdNT1.1 and LdNT1.2 exhibit different electrogenic properties, despite their close sequence homology. This electrophysiological study provides the first demonstration that members of the equilibrative nucleoside transporter family can be electrogenic and establishes that these three permeases, unlike their mammalian counterparts, are probably concentrative rather than facilitative transporters.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12835315     DOI: 10.1074/jbc.M306188200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Nucleoside and nucleobase transporters in parasitic protozoa.

Authors:  Scott M Landfear; Buddy Ullman; Nicola S Carter; Marco A Sanchez
Journal:  Eukaryot Cell       Date:  2004-04

Review 2.  Nutrient transport and pathogenesis in selected parasitic protozoa.

Authors:  Scott M Landfear
Journal:  Eukaryot Cell       Date:  2011-01-07

3.  An acid-activated nucleobase transporter from Leishmania major.

Authors:  Diana Ortiz; Marco A Sanchez; Hans P Koch; H Peter Larsson; Scott M Landfear
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

Review 4.  Dependence of Leishmania parasite on host derived ATP: an overview of extracellular nucleotide metabolism in parasite.

Authors:  Kashika Arora; Ambak Kumar Rai
Journal:  J Parasit Dis       Date:  2018-12-01

Review 5.  Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets.

Authors:  Mahmoud H El Kouni
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2017-07-21       Impact factor: 2.231

6.  Identification of the intracellular gate for a member of the equilibrative nucleoside transporter (ENT) family.

Authors:  Raquel Valdés; Johannes Elferich; Ujwal Shinde; Scott M Landfear
Journal:  J Biol Chem       Date:  2014-02-04       Impact factor: 5.157

7.  Uridine-ribohydrolase is a key regulator in the uridine degradation pathway of Arabidopsis.

Authors:  Benjamin Jung; Martin Flörchinger; Hans-Henning Kunz; Michaela Traub; Ruth Wartenberg; Wolfgang Jeblick; H Ekkehard Neuhaus; Torsten Möhlmann
Journal:  Plant Cell       Date:  2009-03-17       Impact factor: 11.277

8.  Cysteine cross-linking defines the extracellular gate for the Leishmania donovani nucleoside transporter 1.1 (LdNT1.1).

Authors:  Raquel Valdés; Ujwal Shinde; Scott M Landfear
Journal:  J Biol Chem       Date:  2012-11-13       Impact factor: 5.157

9.  Electrophysiological characterization of a recombinant human Na+-coupled nucleoside transporter (hCNT1) produced in Xenopus oocytes.

Authors:  Kyla M Smith; Amy M L Ng; Sylvia Y M Yao; Kathy A Labedz; Edward E Knaus; Leonard I Wiebe; Carol E Cass; Stephen A Baldwin; Xing-Zhen Chen; Edward Karpinski; James D Young
Journal:  J Physiol       Date:  2004-06-11       Impact factor: 5.182

Review 10.  Transporters for drug delivery and as drug targets in parasitic protozoa.

Authors:  S M Landfear
Journal:  Clin Pharmacol Ther       Date:  2009-07-01       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.